Immunohistochemistry data showed that VGFR3 is associated with vascularization and hepatic metastasis in CRC patients (53), while several studies have shown that expression of AXL was elevated in advanced CRC, which may be associated with poor survival (54). This evidence concerns the gene AXL and colorectal carcinoma.